2012
DOI: 10.1136/gutjnl-2012-302615
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of spleen tyrosine kinase as treatment of postoperative ileus

Abstract: The Syk inhibitor GSK143 reduces macrophage activation and mast cell degranulation in vitro. In addition, it inhibits manipulation-induced intestinal muscular inflammation and restores intestinal transit in mice. These findings suggest that Syk inhibition may be a new tool to shorten POI.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
16
0
1

Year Published

2013
2013
2025
2025

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(19 citation statements)
references
References 46 publications
2
16
0
1
Order By: Relevance
“…The degranulation and consequent release of inflammatory mediators can in turn activate sensory nerves, a phenomenon involved in the pathophysiology of irritable bowel syndrome (IBS) 68 and POI. The use of mast cell stabilizer doxantrazole 69 or an inhibitor of Syk, 70 a kinase involved in the downstream signaling of SP receptors, showed its efficacy in dampening the inflammation in POI in mice. Although the SP-mast cells interaction is a key event in IBS and POI, the neuronal source of this neurotransmitter (i.e., enteric neurons or vagal sensory afferents) remains unclear 71 …”
Section: Intestinal Neuro-immune Interactionsmentioning
confidence: 99%
“…The degranulation and consequent release of inflammatory mediators can in turn activate sensory nerves, a phenomenon involved in the pathophysiology of irritable bowel syndrome (IBS) 68 and POI. The use of mast cell stabilizer doxantrazole 69 or an inhibitor of Syk, 70 a kinase involved in the downstream signaling of SP receptors, showed its efficacy in dampening the inflammation in POI in mice. Although the SP-mast cells interaction is a key event in IBS and POI, the neuronal source of this neurotransmitter (i.e., enteric neurons or vagal sensory afferents) remains unclear 71 …”
Section: Intestinal Neuro-immune Interactionsmentioning
confidence: 99%
“…In the mouse small bowel, GSK143 reduced the manipulation-induced production of proinflammatory, macrophage-derived cytokines. Finally, GSK143 improved intestinal transit and reduced recruitment of neutrophils and monocytes to the muscularis externa of the manipulated bowel 9. The inhibitory effects of GSK143 on mast cell and on macrophage are interesting as simultaneous targeting of both cell types might counteract their synergistic actions in POI pathophysiology, enhancing treatment.…”
mentioning
confidence: 99%
“…Mast cell stabilisation with ketotifen or doxantrazole, and macrophage inhibition with semapimod improved the inflammatory-dysmotility component of POI in a clinical trial7 and an animal study 8. Van Bree et al 9 investigated the therapeutic effect of a novel spleen tyrosine kinase inhibitor GSK143 on cultured mast cells and macrophages and in mouse POI. Their in vitro results demonstrate that GSK143 can inhibit mediator release from mast cells evoked either by Substance P or by IgE crosslinking, indicating broad inhibition of mediator release.…”
mentioning
confidence: 99%
“…The mechanism of POI is complex, characterized mainly by intestinal inflammatory infiltration343536. In traditional Chinese medicine, SMD and acupuncture at the tsusanli acupoint have long been used to reduce risk of POI and manage various functional gastrointestinal disorders8937.…”
Section: Discussionmentioning
confidence: 99%